Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What should investors watch in ONE Gas OGS stock today Q4 2025 Below Expectations What Willamette WVVIP does that makes it resilient Bearish Sentiment 20260510 What Eureka EURK is doing that smart money tracks Calm 20260508 DRDGOLD DRD Moat Analysis Q3 2014 Earnings Beat Estimates Deere Company DE OS OSTX Stock Builds Base Volatility Increases 20260420 ADEA Adeia posts robust Q4 2025 earnings with 179 percent annual revenue growth 296 percent EPS beat and mild share gains Endeavour EXK Delivers Q1 2026 Beat EPS 021 vs 013 Expected Gold and Silver Decline on Comex as Precious Metals Slide Lower April Jobs Report Labor Market Cooling but Remains Resilient Key Takeaways Samsung Electronics Workers to Strike as Wage Talks Collapse Shares Slide DigiAsset Wt DAAQW Rallies 883 as Bulls Target 044 20260519 GRAIL GRAL Down 348 How Low Could It Go 20260517 HRS Aluglaze Shares Surge 6 After Strong Q4 FY26 Results Revenue Up 60 Profit Nearly Doubles Etsy Gets Upgrade While ZoomInfo Faces Downgrade Wall Street Analyst Calls MACOM MTSI and IQE plc Forge LongTerm Supply Agreements Novartis Raises FullYear Sales and Profit Guidance Signaling Strong Operational Performance Apollo Global and Blackstone Reportedly Working on 36 Billion Debt Financing for Anthropic Destiny 2 Support Ending Potential Implications for Bungie and Sonys LiveService Strategy GPK Q1 2026 Earnings EPS Beats Estimates by 56 Stock Edges Higher Teradyne Q1 2026 Earnings Strong EPS Beat Driven by Robust Demand in Semiconductor Test Latham Group SWIM Q1 2026 Earnings EPS Surprise Drives Shares Higher CKX Q1 2025 Earnings Modest EPS Amid Quiet Quarter JMIA Q4 2025 Earnings Significant EPS Miss Sends Stock Lower RIME Q1 2026 Earnings EPS Beats Estimates by 30 Shares Surge Over 8 FatPipe Inc FATN Surges 16 Key Levels and Technical Outlook Radiopharm Theranostics RADX Gains Ground Testing Key Resistance at 485 Gain Therapeutics GANX Climbs Higher as Bullish Momentum Builds Near Resistance BioMarin Pharmaceutical BMRN Holds Steady Near Support as Investors Evaluate Pipeline Progress Criteo CRTO Rallies Over 4 to 1787 Approaching Key Resistance Near 1876